Nuwellis NUWE 深 沪
交易中 05-11 11:53:29 美东时间
1.04
-0.050
-4.59%
华盛通- 最 高1.13
- 今 开1.07
- 成交量 1.95万股
- 最 低 1.04
- 昨 收 1.09
- 总市值 1.10万
- 52周最高 25.95
- 市盈率 静 --
- 换手率 185.18%
- 52周最低 0.19
- 委 比 -48.47%
- 总股本 1.05万
- 历史最高 13692.00
- 量 比 1.50
- 振 幅 8.26%
- 历史最低 0.101
- 每 手 1
- 风险率 2.79%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Nuwellis Reports ~50% Of U.S. Revenue In 2025
Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces continued momentum in its pediatric category, which is now the Company's
03-31 20:33
Nuwellis Earnings Preview
Nuwellis (NASDAQ:NUWE) is gearing up to announce its quarterly earnings on Tues...
03-10 00:02
Nuwellis Appoints Carisa Schultz CFO, Effective Feb. 2
Nuwellis, Inc. (Nasdaq: NUWE) a medical technology company focused on advancing precision cardiorenal care, today announced the appointment of Carisa Schultz as Chief Financial Officer, effective February 2, 2026.Ms.
01-30 21:06
Dow Falls Over 300 Points; General Motors Posts Upbeat Earnings
U.S. stocks traded mixed this morning, with the Dow Jones index falling more th...
01-27 22:38
Nuwellis Announces A Leading Northeastern U.S. Children's Hospital Has Initiated An Aquadex Ultrafiltration Program
Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company committed to delivering solutions for patients with cardio-renal conditions, announced today that a leading Northeastern U.S. children's hospital has initiated
2025-12-04 21:16
Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering
Nuwellis, Inc. announces a public offering of 406,755 common shares and warrants, priced at $0.30 per share and $0.2999 for pre-funded warrants. Proceeds will support working capital and potential acquisitions. The company, based in Minneapolis, focuses on treating fluid overload with its Aquadex SmartFlow system.
2025-06-09 13:15
Nuwellis Q4 2024 GAAP EPS $(0.44) Misses $(0.43) Estimate, Sales $2.32M Miss $2.46M Estimate
Nuwellis (NASDAQ:NUWE) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.43) by 2.33 percent. This is a 99.19 percent increase over losses of $(54.48) per share from the
2025-03-11 20:03
Earnings Scheduled For March 11, 2025
Companies Reporting Before The Bell • Exagen (NASDAQ:XGN) is projected to repor...
2025-03-11 16:32
古特拉盘中异动 大幅下跌5.44%报0.661美元
北京时间2024年10月24日02时32分，古特拉（CUTR.us）股票出现异动，股价大幅下挫5.44%。截至发稿，该股报0.661美元/股，成交量12.0112万股，换手率0.59%，振幅3.12%。 最近的财报数据显示，该股实现营业收入34.38百万美元，净利润-24.68百万美元，每股收益-1.23美元，毛利6.27百万美元，市盈率-0.09倍。 机构评级方面，在所有4家参与评级的机构中，25%的券商给予买入建议，75%的券商给予持有建议，无券商给予卖出建议。 古特拉股票所在的医疗器械行业中，整体跌幅为0.49%。其相关个股中，Tenon Medical Inc C/Wts 16/06/...
2024-10-24 02:32
